By InvitationNot Applicable

A Randomized Controlled Trial of Menopausal Tool/App for Women

United States450 participantsStarted 2025-05-07

Plain-language summary

The purpose of this study is about assessing the utilization of a mobile phone application (app), designed to improve the menopause experience of midlife women experiencing related symptoms and its association with menopause-related health care utilization

Who can participate

Age range24 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

For Patient Enrollment: Inclusion Criteria: * Women between the ages of 45 and 55 * English speaking (app only available in English) * Able to provide informed consent * Experiencing menopause symptoms, which will be assessed by a Menopause Rating Scale (MRS) survey score of ≥ 5 * Has an upcoming Mayo Clinic primary care appointment within 3 weeks of the enrollment and the MRS survey Exclusion Criteria: * Lack of willingness to engage with app * Inability to provide informed consent

What they're measuring

Frequency of app logins among intervention group.

Timeframe: Up to 6 weeks

Compare differences in rates of menopause treatment among intervention and comparison groups.

Timeframe: Up to 6 weeks

Mean score on a validated survey assessing perceived importance and availability of healthcare services for women's health conditions/concerns related to menopause

Timeframe: through study completion, an average of 1 year

Percentage of healthcare professionals reporting 'high' & 'low' confidence in diagnosing and managing menopause symptoms

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT06919887

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-05-15

View on ClinicalTrials.gov More Menopausal Symptoms trials